U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07456059) titled 'A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults' on March 03.
Brief Summary: The purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after single and multiple doses in Japanese and Caucasian adults. The safety of EDG-7500 in these adult participants will also be evaluated in this study.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: EDG-7500
Solid oral formulation of EDG-7500
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Edgewise Therapeutics, Inc.
Disclaimer: Curated by HT Syndication....